期刊文献+

早期介入治疗对非ST段抬高性急性冠脉综合征患者生存率的影响

Effect of Early Interventional Therapy on Survival Rate in Patients with Non-ST-segment Elevation Acute Coronary Syndrome
下载PDF
导出
摘要 目的探讨早期介入治疗对辽宁地区非ST段抬高性急性冠脉综合征患者生存率的影响。方法自2006年3月至2007年1月入院并接受介入治疗的非ST段抬高急性冠脉综合征患者226例,男153例,女73例,平均年龄(61.1±10.7)岁。分为入院48 h内介入治疗组和入院48 h后介入治疗组。通过门诊、病历记录或电话随访,随访30 d、90 d、180 d的心血管事件(包括心脏性死亡、非致命性心肌梗死、非致命性心力衰竭、缺血性心绞痛)。结果入院48 h内介入治疗组、48 h后介入治疗组患者基线特征比较:入院48 h内介入治疗组患者年龄(59.2±10.1)岁,48 h后介入治疗组(63.1±10.9)岁,两组比较差异显著(P<0.01);两组出院后180 d生存率比较无显著差异(P>0.05)。结论入院48 h内的介入治疗与入院48 h后的介入治疗对辽宁地区非ST段抬高性急性冠脉综合征患者的出院后180 d生存率的影响无明显差别。 Objective To study the effect of early interventional therapy on the survival rate in patients with non-ST-segment elevation acute coronary syndrome. Methods Totally 226 patients (including 153 men and 73 women,with a mean age of 61.1±10.7 years) with non-ST- segment elevation acute coronary syndrome who admitted to hospital from March 2006 to January 2007 were included. The patients underwent interventional therapy within 48 hours of admission (group A) or 48 hours after admission (group B ). The patients were followed up, and the incidences of cardiovascular events 30,100, and 180 days after hospital discharge were recorded. Results The mean ages were 59.2±10.1 years in group A and 63.1±10.9 years in group B,and there was significant difference in the mean age between 2 groups (P = 0.301 ). No statistically significant difference in the survival rate 180 days after hospital discharge was observed between 2 groups. Conclusion In patients with non-ST-segment elevation acute coronary syndrome, there, is no significant difference in survival rate 180 days after hospital discharge between patients undergoing interventional therapy within 48 hours of admission and those undergoing interventional therapy 48 hours after admission.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2009年第6期462-464,共3页 Journal of China Medical University
关键词 非ST段抬高性急性冠脉综合征 早期介入治疗 多中心研究 non-ST-segment elevation acute coronary syndrome early interventional therapy multi-center study
  • 相关文献

参考文献7

  • 1Roe MT,Peterson ED,Pollack CV JR, et al. Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes [ J ]. Ann Emerg Med, 2005,45 (4) : 355-362.
  • 2Roe MT, Mahaffey KW, Kilaru R, et al Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes [J]. Eur Heart J,2004,25 (4) :313-321.
  • 3Benderly M, Graffe E, Reicher-reiss H, et al. Fibinogen is predictor of mortility in coronary artery disease patients:the Bezafibrate Infarction Prevention (BIP) STUDY Group [J]. Arterioscler Thromb Vase Biol, 1996,16 ( 3 ) : 351-356.
  • 4Freedman DS,Williamson DF,Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANESL epidemiologic follow up study[J].Am J Epidemiol, 1995,141 (7) : 637-644.
  • 5Levine W,Dyer AR,Shekelle RB,et a 1. Serum uric acid and 11.5- year mortality of middle-aged women [J]. J Clin Epidemiol, 1989,42 (3) : 257-267.
  • 6Biasucci LM, Liuzz G, Grillo RL, et al. Elevated levels of C-reactive protein at disdischarge in patients with unstable angina predict recurrent instability [J]. Circulation, 1999,99(7 ) :855-860.
  • 7Morrow DA,de Lemos JA,Sabatine MS,et al. Evaluation of B -type natriuretic peptide for risk assessment in unstable angina/non -ST - elevation myocardial infarction : B - type natriuretic peptide andprognosis in TACTICS - TIMI 18 [ J ]. Am Coll Cardiol, 2003, 41 (10) : 1852-1856.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部